Skip to main content
Veterinary Medicines

Fipnil 67 mg Spot-on Solution for small dogs

Authorised
  • Fipronil

Product identification

Medicine name:
Fipnil 67 mg Spot-on Solution for small dogs
Fipnil 67 mg Spot-on Solution for small dogs
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Topical use

Product details

Active substance and strength:
  • Fipronil
    67.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Topical use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 15 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 12 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 10 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 9 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 8 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 6 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 60 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 30 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 24 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 21 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 20 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 18 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 150 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 90 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 4 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 3 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 2 pipettes in individual foil sachets.
  • A 0.67ml white pipette composed of a heat-formed shell of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer. A Cardboard box with 1 pipette in individual foil sachets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10987/095/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0280/001
Concerned member states:
  • France
  • Hungary
  • Italy
  • Malta
  • Poland
  • Romania
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."